News & ArticlesLatest news and informative articles
The EU Pilot for 2 Member States to gain simultaneous national scientific advice is launched on 1st February. Find out more here.
Two Months to Go – Human medicinal product licences to be reviewed for the presence of Nitrosamine Impurities
We revisit Estimands after it’s adoption in November. Find out how we can help.
It’s been a fantastic year for S-cubed. Read the reviews from our three managing directors in the UK and Denmark.
Nitrosamines, TOPRA, & Drug Development News are the focus for our Q4 Industry Insights
S-cubed is pleased to announce the launch of the A3 Community MDR provided free for the benefit of the CDISC user community.
Elizabeth Merrall discusses the case for using real world data (RWD) in clinical research.
We’re at a number of events between now and the end of November, demonstrating our clinical data expertise. Get in touch if you’d like a meeting.
Global Harmonisation of Clinical Trials is the latest focus for our quarterly roundup of the regulatory landscape with news from EMA, FDA and ICH
This month we explain how S-cubed can assist you in applying the forthcoming regulatory guidance ICH E9(R1)
The CDISC 360 Project is a major change in the way we access and use standards. Our A3 Suite is ready and tuned to the vision.
It’s been a busy few months for S-cubed. Find out where we’ve been and where we’re going to next.
Statistics and the impact of machine learning get Elizabeth Merrall thinking and considering the future.
Our latest Industry Insights focuses on Brexit and news from the regulators around the globe.
As we head to the CDISC Interchange this week, make sure you see our presentations and meet our team at Stand 11.
S-cubed is pleased to announce that S-cubed and A3 Informatics have merged to bring the A3 Suite of tools inside the S-cubed brand.
Regulatory Affairs and Quality Assurance – S-cubed Ltd are 10 years old. Find out about how our team came together and continue to grow.
The latest papers and presentations from PhUSE US Connect in Baltimore and our future events, including CDISC.
Our first Industry Insights of 2019 focuses on the latest regulatory developments and Brexit.
A fascinating talk by the Keynote Speaker, Dr Ahadpour from the FDA on the opioid addiction crisis in the USA.
Jakob Sandersen reports on the exciting developments at Pharmaceutical Services ApS over the last 15 months.
No Results Found
The page you requested could not be found. Try refining your search, or use the navigation above to locate the post.
Sign up to receive our newsletters
The industry insights features the latest news and developments from the pharmaceutical industry.
Sign up for our newsletter
Download our latest publication
Featured in this issue of Industry Insights:
- COVID – 19 Guidance Updates
- Regulations and Guidance
- Serious Breaches
If you want to contribute or share something that you’d like to be listed in the next issue, please feel free to contact us.